NULISA
LIVE

Serial Number

50017184

Owner

Alamar Biosciences, Inc.

Attorney

Hillary I. Schroeder

Filing Date

Jul 28, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NULISA Trademark

Serial Number: 50017184

NULISA is a trademark filed by Alamar Biosciences, Inc. on July 28, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Alamar Biosciences, Inc. (13 trademarks)

47071 Bayside Parkway
Fremont, CA 94538

Entity Type: 03

Trademark Details

Filing Date

July 28, 2026

Registration Date

Not Registered

Goods & Services

Medical diagnostic assays for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic assays for testing body fluids; Medical diagnostic assays for analyzing potential cancer treatments; Diagnostic agents, preparations and substances for medical use; Medical diagnostic assays for detecting and analyzing infectious disease; Medical diagnostic assays for detecting and analyzing proteins and proteomic changes; Medical diagnostic assays for detecting and analyzing neurological disease; Medical diagnostic assays for detecting and analyzing autoimmune and inflammatory disorders; Medical diagnostic assays for detecting and analyzing respiratory disease; Medical diagnostic assays for detecting and analyzing progression of cancer

Scientific research and development; Providing scientific research information; Scientific research in the field of genetics; Scientific research consulting in the field of proteomics; Genetic testing for scientific research purposes; Blood analysis for scientific research purposes; Blood testing for scientific research purposes; Providing temporary use of online non-downloadable computer software for analysis of biological data; Providing temporary use of online non-downloadable computer software for analysis of proteomics data

Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Medical laboratory research instruments for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical laboratory research instruments for detecting proteins and proteomic changes; Medical laboratory research instruments for detecting and analyzing neurological disease; Medical laboratory research instruments for detecting and analyzing autoimmune and inflammatory disorders; Medical laboratory research instruments for detecting and analyzing respiratory disease; Medical laboratory research instruments for detecting and analyzing infectious disease; Medical laboratory research instruments for progression of cancer; Medical laboratory research instruments for analyzing potential cancer treatments; Medical laboratory research instruments for performing proteomics assays for research and diagnostic purposes; Downloadable software for analysis of biological data; Downloadable software for analysis of proteomics data

Medical diagnostic apparatus for detecting proteins in biological fluids such as plasma, cerebral spinal fluid, tears, or urine; Medical diagnostic apparatus for detecting proteins and proteomic changes; Medical diagnostic apparatus for detecting presence and progression of neurological disease; Medical diagnostic apparatus for detecting presence and progression of autoimmune and inflammatory disorders; Medical diagnostic apparatus for detecting presence and progression of respiratory disease; Medical diagnostic apparatus for detecting presence and progression of infectious disease; Medical diagnostic apparatus for detecting presence and progression of cancer; Genetic testing apparatus for medical purposes; Apparatus for blood analysis

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 28, 2026 MAFR
NEW APPLICATION ENTERED
Jul 28, 2026 NWAP